Defying the odds: 30 years in AL amyloidosis research-recent barriers to clinical trial enrollment
Blood Adv
.
2024 Nov 26;8(22):5826-5828.
doi: 10.1182/bloodadvances.2024014262.
Authors
Vaishali Sanchorawala
1
,
Bruna Barroso
2
,
Anthony Shelton
2
,
Elise Goetz
2
,
Lisa Mendelson
1
,
Tracy Joshi
1
,
Natasha Burke
1
,
J Mark Sloan
1
,
Andrew Staron
1
Affiliations
1
Department of Medicine, Amyloidosis Center, Boston University Chobanian & Avedisian School of Medicine, Boston Medical Center, Boston, MA.
2
Department of Medicine, Cancer and Hematology Clinical Research Program, Boston Medical Center, Boston, MA.
PMID:
39293090
PMCID:
PMC11609355
DOI:
10.1182/bloodadvances.2024014262
No abstract available